Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongnan Mo

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Breast (Edinburgh, Scotland)|December 14, 2020
Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in ChinaYiqun Li, Qiao Li, Hongnan Mo, et al.
Cancer Cell|October 15, 2021
Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancerYuanyuan Zhang, Hongyan Chen, Hongnan Mo, et al.
Signal Transduction and Targeted Therapy|February 6, 2025
Neoadjuvant apatinib addition to sintilimab and carboplatin-taxane based chemotherapy in patients with early triple-negative breast cancer: the phase 2 NeoSAC trialGuoshuang Shen, Zhilin Liu, Miaozhou Wang, et al.
Communications Medicine|March 30, 2026
Machine learning survival model for personalised prevention of catheter-related thrombosis in tumour patientsHewei Ge, Qiao Liu, Junying Xie, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Breast (Edinburgh, Scotland)|December 14, 2020
Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in ChinaYiqun Li, Qiao Li, Hongnan Mo, et al.
Cancer Cell|October 15, 2021
Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancerYuanyuan Zhang, Hongyan Chen, Hongnan Mo, et al.
Signal Transduction and Targeted Therapy|February 6, 2025
Neoadjuvant apatinib addition to sintilimab and carboplatin-taxane based chemotherapy in patients with early triple-negative breast cancer: the phase 2 NeoSAC trialGuoshuang Shen, Zhilin Liu, Miaozhou Wang, et al.
Communications Medicine|March 30, 2026
Machine learning survival model for personalised prevention of catheter-related thrombosis in tumour patientsHewei Ge, Qiao Liu, Junying Xie, et al.
Pageof 6